What laboratory tests are needed for a patient suspected of having Neuroleptic Malignant Syndrome (NMS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Neuroleptic Malignant Syndrome

When NMS is suspected, immediately order creatine kinase (CK), complete blood count (CBC) with differential, comprehensive metabolic panel including electrolytes and liver function tests, and urinalysis—these labs support the diagnosis and guide management of life-threatening complications. 1

Essential Laboratory Tests

Primary Diagnostic Labs

  • Creatine kinase (CK) is the single most important laboratory marker, typically elevated ≥4 times the upper limit of normal and often reaching levels of 1000-10,000 U/L due to muscle breakdown from sustained rigidity 1, 2

  • Complete blood count (CBC) reveals leukocytosis in the range of 15,000 to 30,000 cells/mm³ in most cases, which helps distinguish NMS from other conditions 1, 2

  • Comprehensive metabolic panel including electrolytes (sodium, potassium, calcium, magnesium), blood urea nitrogen, and creatinine to identify dehydration and assess for acute kidney injury from rhabdomyolysis 1, 3

  • Liver function tests (AST, ALT, alkaline phosphatase, LDH) are frequently elevated due to muscle breakdown and systemic stress, with transaminases often in the range of 45-55 IU/L or higher 1, 4

Additional Critical Labs

  • Urinalysis to detect myoglobinuria from rhabdomyolysis, which appears as positive blood on dipstick without red blood cells on microscopy 3

  • Arterial blood gas to check for metabolic acidosis, which occurs in severe cases and indicates poor prognosis 1

  • Serum iron level is characteristically low in NMS and helps differentiate it from serotonin syndrome 5

Labs to Rule Out Alternative Diagnoses

Because NMS is a clinical diagnosis with no pathognomonic findings, you must obtain labs to exclude infectious, toxic, metabolic, and neurologic mimics—this exclusion is worth 7 points in expert diagnostic criteria. 1

Infectious Workup

  • Blood cultures (at least two sets) to rule out sepsis, which can present with fever, altered mental status, and tachycardia 3

  • Lumbar puncture with CSF analysis (cell count, protein, glucose, Gram stain, culture) to exclude meningitis or encephalitis if there are no contraindications 3

Toxicologic and Metabolic Screen

  • Toxicology screen (urine and serum) to identify concurrent drug intoxication or withdrawal syndromes 3

  • Thyroid function tests (TSH, free T4) to exclude thyroid storm, which presents with hyperthermia and autonomic instability 3

  • Calcium and magnesium levels as hypercalcemia can cause altered mental status and hypocalcemia can cause muscle rigidity 3

Additional Diagnostic Studies

  • Electrocardiogram (ECG) to identify sinus tachycardia (common in NMS) and rule out cardiac arrhythmias 4

  • Coagulation studies (PT, PTT, fibrinogen, D-dimer) if disseminated intravascular coagulation is suspected in severe cases 1

  • Electroencephalogram (EEG) if seizures are suspected or to rule out nonconvulsive status epilepticus 3

  • Brain imaging (CT or MRI) to exclude structural lesions, though this is typically normal in NMS 3

Laboratory Monitoring During Treatment

  • Serial CK measurements every 6-12 hours initially to track rhabdomyolysis progression and response to treatment 2, 3

  • Daily basic metabolic panel to monitor electrolytes and renal function, as acute kidney injury can develop from myoglobinuria 2, 6

  • Daily CBC to track resolution of leukocytosis as a marker of clinical improvement 4

  • Liver enzymes every 1-2 days until normalizing 4

Common Pitfalls to Avoid

  • Do not wait for all lab results before initiating treatment—NMS is a clinical diagnosis and immediate discontinuation of the offending agent plus supportive care should begin as soon as the syndrome is suspected 1, 2, 6

  • Do not dismiss NMS based on normal or mildly elevated CK early in the course—CK may not peak until 24-48 hours after symptom onset 7

  • Do not confuse NMS with serotonin syndrome—while both can have elevated CK, NMS typically shows much higher CK levels (often >1000 U/L), more pronounced leukocytosis, and low serum iron, whereas serotonin syndrome features hyperreflexia and clonus rather than lead-pipe rigidity 1, 5

  • Do not overlook the need for repeat lumbar puncture if initial CSF is equivocal—meningitis/encephalitis must be definitively ruled out given the overlapping presentation 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neuroleptic Malignant Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Neuroleptic malignant syndrome: a review.

Psychiatric services (Washington, D.C.), 1998

Research

Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2012

Research

Progression of symptoms in neuroleptic malignant syndrome.

The Journal of nervous and mental disease, 1994

Related Questions

What is the diagnosis for a patient with worsening psychosis and paranoia, presenting with hyperthermia, tachycardia, hypertension, and rigidity, who is currently receiving risperidone, loperamide, benztropine, and hydroxyzine?
What is the approach to work up a patient with suspected Neuroleptic Malignant Syndrome (NMS)?
What are the differences in treatment and management of malignant hyperthermia, neuroleptic malignant syndrome, and serotonin syndrome?
What is the role of cyproheptadine in the treatment of Neuroleptic Malignant Syndrome (NMS)?
What is the difference in treatment between Neuroleptic Malignant Syndrome (NMS) and Serotonin Syndrome?
What is the best management plan for a patient with limited neck and shoulder mobility, shoulder pain, and cardiovascular comorbidities including irregular heart rate and pedal edema?
What is the diagnosis and treatment for a patient with bleeding behind the eye, possibly taking anticoagulants like warfarin or aspirin?
What is the recommended antibiotic for a pregnant patient with an ear infection who is allergic to Augmentin (amoxicillin-clavulanate)?
What are the considerations for discontinuing trazodone and starting doxepin (Sinequan) 3mg in a patient with a complex psychiatric history, currently taking mirtazapine (Remeron) 30mg at bedtime?
Can statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor) therapy cause a sudden rash?
What is the recommended treatment for a patient with cystic changes in the femoral head, likely due to osteonecrosis or osteoarthritis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.